KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Apr 10, 2024 Buy 0 Dube Michael P Common Stock
Mar 04, 2024 Sell 2 297 Basta James Common Stock
Mar 04, 2024 Sell 605 Clark Eliana Common Stock
Mar 01, 2024 Buy 37 966 Sepp-lorenzino Laura Common Stock
Mar 01, 2024 Buy 54 794 Sepp-lorenzino Laura Stock Option (right to buy)
Mar 01, 2024 Buy 32 394 Basta James Common Stock
Mar 01, 2024 Buy 46 752 Basta James Stock Option (right to buy)
Mar 01, 2024 Buy 29 393 Hicks Derek Common Stock
Mar 01, 2024 Buy 42 421 Hicks Derek Stock Option (right to buy)
Mar 01, 2024 Buy 31 230 Clark Eliana Common Stock
Mar 01, 2024 Buy 45 072 Clark Eliana Stock Option (right to buy)
Mar 01, 2024 Buy 113 586 Leonard John M Common Stock
Mar 01, 2024 Buy 163 929 Leonard John M Stock Option (right to buy)
Mar 01, 2024 Buy 38 701 Lebwohl David Common Stock
Mar 01, 2024 Buy 55 855 Lebwohl David Stock Option (right to buy)
Mar 01, 2024 Buy 28 628 Goddard Glenn Common Stock
Mar 01, 2024 Buy 41 316 Goddard Glenn Stock Option (right to buy)
Jan 08, 2024 Sell 1 608 Sepp-lorenzino Laura Common Stock
Jan 08, 2024 Sell 667 Sepp-lorenzino Laura Common Stock
Jan 03, 2024 Sell 19 223 Leonard John M Common Stock
Jan 03, 2024 Sell 5 843 Lebwohl David Common Stock
Jan 03, 2024 Sell 5 532 Sepp-lorenzino Laura Common Stock
Jan 03, 2024 Sell 5 365 Goddard Glenn Common Stock
Jan 03, 2024 Sell 3 877 Hicks Derek Common Stock
Jan 03, 2024 Sell 3 805 Basta James Common Stock
Jan 03, 2024 Sell 307 Clark Eliana Common Stock
Jan 03, 2024 Sell 4 301 Clark Eliana Common Stock
Jan 01, 2024 Buy 3 500 Sepp-lorenzino Laura Common Stock
Jan 01, 2024 Sell 3 500 Sepp-lorenzino Laura Restricted Stock Unit
Jan 01, 2024 Buy 3 187 Lebwohl David Common Stock
Jan 01, 2024 Sell 3 187 Lebwohl David Restricted Stock Unit
Jan 01, 2024 Buy 7 848 Leonard John M Common Stock
Jan 01, 2024 Sell 7 848 Leonard John M Restricted Stock Unit
Jan 01, 2024 Buy 3 062 Goddard Glenn Common Stock
Jan 01, 2024 Sell 3 062 Goddard Glenn Restricted Stock Unit
Oct 31, 2023 Sell 265 Bhanji Muna Common Stock
Jul 31, 2023 Sell 265 Bhanji Muna Common Stock
Jul 06, 2023 Sell 1 867 Bhanji Muna Common Stock
Jul 03, 2023 Sell 360 Clark Eliana Common Stock
Jun 20, 2023 Sell 5 000 Clark Eliana Stock Option (right to buy)
Jun 20, 2023 Buy 5 000 Clark Eliana Common Stock
Jun 20, 2023 Sell 5 000 Clark Eliana Common Stock
Jun 14, 2023 Buy 1 673 Chase William J Common Stock
Jun 14, 2023 Buy 2 447 Chase William J Stock Option (right to buy)
Jun 14, 2023 Buy 4 425 Verwiel Frank Common Stock
Jun 14, 2023 Buy 6 473 Verwiel Frank Stock Option (right to buy)
Jun 14, 2023 Buy 4 425 Keresty Georgia Common Stock
Jun 14, 2023 Buy 6 473 Keresty Georgia Stock Option (right to buy)
Jun 14, 2023 Buy 4 425 Goodman Jesse Common Stock
Jun 14, 2023 Buy 6 473 Goodman Jesse Stock Option (right to buy)
Jun 14, 2023 Buy 4 425 Crowley John F Common Stock
Jun 14, 2023 Buy 6 473 Crowley John F Stock Option (right to buy)
Jun 14, 2023 Buy 4 425 Cohen Fred E Common Stock
Jun 14, 2023 Buy 6 473 Cohen Fred E Stock Option (right to buy)
Jun 14, 2023 Buy 4 425 Bhanji Muna Common Stock
Jun 14, 2023 Buy 6 473 Bhanji Muna Stock Option (right to buy)
Apr 14, 2023 Buy 10 483 Chase William J Common Stock
Apr 14, 2023 Buy 14 931 Chase William J Stock Option (Right to Buy)
Apr 14, 2023 Buy 0 Chase William J Common Stock
Mar 02, 2023 Sell 1 088 Basta James Common Stock
Mar 01, 2023 Buy 23 558 Hicks Derek Common Stock
Mar 01, 2023 Buy 33 287 Hicks Derek Stock option (right to buy)
Mar 01, 2023 Buy 27 484 Goddard Glenn Common Stock
Mar 01, 2023 Buy 38 834 Goddard Glenn Stock Option (right to buy)
Mar 01, 2023 Buy 91 036 Leonard John M Common Stock
Mar 01, 2023 Buy 128 631 Leonard John M Stock Option (right to buy)
Mar 01, 2023 Buy 30 674 Lebwohl David Common Stock
Mar 01, 2023 Buy 43 342 Lebwohl David Stock Option (right to buy)
Mar 01, 2023 Buy 29 938 Sepp-lorenzino Laura Common Stock
Mar 01, 2023 Buy 42 302 Sepp-lorenzino Laura Stock Option (right to buy)
Mar 01, 2023 Buy 6 134 Clark Eliana Common Stock
Mar 01, 2023 Buy 24 539 Clark Eliana Common Stock
Mar 01, 2023 Buy 34 674 Clark Eliana Stock Option (right to buy)
Mar 01, 2023 Buy 12 269 Basta James Common Stock
Mar 01, 2023 Buy 24 539 Basta James Common Stock
Mar 01, 2023 Buy 34 674 Basta James Stock Option (right to buy)
Jan 05, 2023 Sell 1 641 Sepp-lorenzino Laura Common Stock
Jan 05, 2023 Sell 689 Sepp-lorenzino Laura Common Stock
Jan 04, 2023 Sell 2 508 Sepp-lorenzino Laura Common Stock
Jan 04, 2023 Sell 6 673 Leonard John M Common Stock
Jan 04, 2023 Sell 1 812 Hicks Derek Common Stock
Jan 04, 2023 Sell 2 574 Lebwohl David Common Stock
Jan 04, 2023 Sell 2 427 Goddard Glenn Common Stock
Jan 04, 2023 Sell 1 692 Clark Eliana Common Stock
Jan 04, 2023 Sell 1 138 Basta James Common Stock
Jan 03, 2023 Sell 231 Clark Eliana Common Stock
Jan 01, 2023 Buy 3 500 Sepp-lorenzino Laura Common Stock
Jan 01, 2023 Sell 3 500 Sepp-lorenzino Laura Restricted Stock Unit
Jan 01, 2023 Buy 7 848 Leonard John M Common Stock
Jan 01, 2023 Sell 7 848 Leonard John M Restricted Stock Unit
Jan 01, 2023 Buy 3 187 Lebwohl David Common Stock
Jan 01, 2023 Sell 3 187 Lebwohl David Restricted Stock Unit
Jan 01, 2023 Buy 3 062 Goddard Glenn Common Stock
Jan 01, 2023 Sell 3 062 Goddard Glenn Restricted Stock Unit
Jun 14, 2022 Buy 7 688 Verwiel Frank Stock Option (right to buy)
Jun 14, 2022 Buy 5 197 Verwiel Frank Common Stock
Jun 14, 2022 Buy 7 688 Keresty Georgia Stock Option (right to buy)
Jun 14, 2022 Buy 7 688 Goodman Jesse Stock Option (right to buy)
Jun 14, 2022 Buy 5 197 Goodman Jesse Common Stock
Jun 14, 2022 Buy 5 197 Formela Jean Francois Common Stock
INSIDER POWER
83.422
Last 100 transactions
Buy: 1 561 723 | Sell: 123 854 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 83.422.

In total, the insiders bought 1 561 723 and sold 123 854 NTLA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Intellia Therapeutics Inc

Intellia Therapeutics Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline... NTLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT